HealthEquity (NASDAQ: HQY) reported Q2 EPS of $0.16, $0.03 better than the analyst estimate of $0.13. Revenue for the quarter came in at $44.2 million versus the consensus estimate of $43.38 million.

GUIDANCE:

HealthEquity sees FY2017 revenue of $174-178 million, versus prior guidance of $173-177 million and the consensus of $176.5 million.

For earnings history and earnings-related data on HealthEquity (HQY) click here.